Randomized comparison of olanzapine versus risperidone for the treatment of first-episode schizophrenia: 4-month outcomes.

@article{Robinson2006RandomizedCO,
  title={Randomized comparison of olanzapine versus risperidone for the treatment of first-episode schizophrenia: 4-month outcomes.},
  author={Delbert G Robinson and Margaret G Woerner and Barbara A Napolitano and Raman C Patel and Serge M Sevy and Handan Gunduz-Bruce and Jose M Soto-Perello and Alan J Mendelowitz and Ali None Khadivi and Rachel F Miller and J Mccormack and Beth S Lorell and Martin L. Lesser and Nina Schooler and John M. Kane},
  journal={The American journal of psychiatry},
  year={2006},
  volume={163 12},
  pages={2096-102}
}
OBJECTIVE The authors compared 4-month treatment outcomes for olanzapine versus risperidone in patients with first-episode schizophrenia spectrum disorders. METHOD One hundred twelve subjects (70% male; mean age=23.3 years [SD = 5.1]) with first-episode schizophrenia (75%), schizophreniform disorder (17%), or schizoaffective disorder (8%) were randomly assigned to treatment with olanzapine (2.5-20 mg/day) or risperidone (1-6 mg/day). RESULTS Response rates did not significantly differ… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 41 extracted citations

Similar Papers

Loading similar papers…